Do analysts rate ZBH or STVN?

Zimmer Biomet currently has a consensus price target of $102.33, suggesting a potential upside of 8.76%. Given Zimmer Biomet's higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 3 Sell rating(s) 13 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.25 Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83

Does the media refer more to ZBH or STVN?

In the previous week, Zimmer Biomet had 10 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Zimmer Biomet and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Zimmer Biomet's score of 1.16 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer SOLV or STVN?

Solventum currently has a consensus price target of $83.67, suggesting a potential upside of 7.98%. Given Solventum's higher possible upside, research analysts clearly believe Solventum is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43 Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83

Does the media favor SOLV or STVN?

In the previous week, Solventum had 8 more articles in the media than Stevanato Group. MarketBeat recorded 9 mentions for Solventum and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Solventum's score of 1.32 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend SNN or STVN?

Smith & Nephew SNATS currently has a consensus target price of $30.93, suggesting a potential downside of 0.49%. Given Smith & Nephew SNATS's higher probable upside, research analysts clearly believe Smith & Nephew SNATS is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83

Which has preferable valuation and earnings, SNN or STVN?

Smith & Nephew SNATS has higher revenue and earnings than Stevanato Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.13 $625M N/A N/A Stevanato Group €1.34B 4.46 €158.21M €0.59 33.52

Does the media prefer SNN or STVN?

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Smith & Nephew SNATS and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Smith & Nephew SNATS's score of 0.76 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend PEN or STVN?

Penumbra currently has a consensus price target of $360.33, suggesting a potential upside of 13.09%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 1 Sell rating(s) 14 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.11 Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83

Which has stronger earnings & valuation, PEN or STVN?

Penumbra has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.45B 8.62 $177.69M $4.34 73.41 Stevanato Group €1.34B 4.46 €158.21M €0.59 33.52

Is PEN or STVN more profitable?

Penumbra's return on equity of 10.87% beat Stevanato Group's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Stevanato Group 11.76% 10.27% 6.08%

Does the media prefer PEN or STVN?

In the previous week, Penumbra had 2 more articles in the media than Stevanato Group. MarketBeat recorded 3 mentions for Penumbra and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Penumbra's score of 0.00 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend STVN or GKOS?

Glaukos has a consensus price target of $151.77, suggesting a potential downside of 0.65%. Given Glaukos' higher possible upside, analysts plainly believe Glaukos is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83 Glaukos 1 Sell rating(s) 1 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.80

Which has better valuation & earnings, STVN or GKOS?

Stevanato Group has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stevanato Group €1.34B 4.46 €158.21M €0.59 33.52 Glaukos $551.35M 16.27 -$187.69M -$3.28 N/A

Is STVN or GKOS more profitable?

Stevanato Group has a net margin of 11.76% compared to Glaukos' net margin of -34.34%. Stevanato Group's return on equity of 10.27% beat Glaukos' return on equity. Company Net Margins Return on Equity Return on Assets Stevanato Group 11.76% 10.27% 6.08% Glaukos -34.34% -6.92% -5.25%

Does the media prefer STVN or GKOS?

In the previous week, Glaukos had 9 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for Glaukos and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Glaukos' score of 0.65 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Glaukos 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Stevanato Group (STVN) Competitors

€19.77 -0.01 (-0.03%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

€19.78 +0.01 (+0.03%)

As of 07/13/2026 04:10 PM Eastern

Compare

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

Should you buy Stevanato Group stock or one of its competitors? MarketBeat compares Stevanato Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Stevanato Group include Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), and Glaukos (GKOS). These companies are all part of the "medical equipment" industry.

How does Stevanato Group compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Stevanato Group has a net margin of 11.76% compared to Zimmer Biomet's net margin of 9.05%. Zimmer Biomet's return on equity of 13.24% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Stevanato Group	11.76%	10.27%	6.08%

Zimmer Biomet has higher revenue and earnings than Stevanato Group. Zimmer Biomet is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.21	$705.20M	$3.85	24.44
Stevanato Group	€1.34B	4.46	€158.21M	€0.59	33.52

In the previous week, Zimmer Biomet had 10 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Zimmer Biomet and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Zimmer Biomet's score of 1.16 indicating that Stevanato Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Zimmer Biomet has a beta of 0.46, suggesting that its stock price is 54% less volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

88.9% of Zimmer Biomet shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Zimmer Biomet currently has a consensus price target of $102.33, suggesting a potential upside of 8.76%. Given Zimmer Biomet's higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.25
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83

Summary

Zimmer Biomet beats Stevanato Group on 10 of the 17 factors compared between the two stocks.

How does Stevanato Group compare to Solventum?

Solventum (NYSE:SOLV) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Solventum currently has a consensus price target of $83.67, suggesting a potential upside of 7.98%. Given Solventum's higher possible upside, research analysts clearly believe Solventum is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83

Solventum has higher revenue and earnings than Stevanato Group. Solventum is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.61	$1.56B	$8.16	9.50
Stevanato Group	€1.34B	4.46	€158.21M	€0.59	33.52

In the previous week, Solventum had 8 more articles in the media than Stevanato Group. MarketBeat recorded 9 mentions for Solventum and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Solventum's score of 1.32 indicating that Stevanato Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Solventum has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Solventum has a net margin of 17.33% compared to Stevanato Group's net margin of 11.76%. Solventum's return on equity of 23.51% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
Stevanato Group	11.76%	10.27%	6.08%

Summary

Solventum beats Stevanato Group on 9 of the 15 factors compared between the two stocks.

How does Stevanato Group compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Smith & Nephew SNATS currently has a consensus target price of $30.93, suggesting a potential downside of 0.49%. Given Smith & Nephew SNATS's higher probable upside, research analysts clearly believe Smith & Nephew SNATS is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83

Stevanato Group has a net margin of 11.76% compared to Smith & Nephew SNATS's net margin of 0.00%. Stevanato Group's return on equity of 10.27% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Stevanato Group	11.76%	10.27%	6.08%

Smith & Nephew SNATS has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Smith & Nephew SNATS has higher revenue and earnings than Stevanato Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.13	$625M	N/A	N/A
Stevanato Group	€1.34B	4.46	€158.21M	€0.59	33.52

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Smith & Nephew SNATS and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Smith & Nephew SNATS's score of 0.76 indicating that Stevanato Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Stevanato Group beats Smith & Nephew SNATS on 9 of the 15 factors compared between the two stocks.

How does Stevanato Group compare to Penumbra?

Penumbra (NYSE:PEN) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

88.9% of Penumbra shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Penumbra has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41
Stevanato Group	€1.34B	4.46	€158.21M	€0.59	33.52

In the previous week, Penumbra had 2 more articles in the media than Stevanato Group. MarketBeat recorded 3 mentions for Penumbra and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Penumbra's score of 0.00 indicating that Stevanato Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Penumbra has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Penumbra currently has a consensus price target of $360.33, suggesting a potential upside of 13.09%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83

Penumbra's return on equity of 10.87% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Stevanato Group	11.76%	10.27%	6.08%

Summary

Penumbra beats Stevanato Group on 12 of the 16 factors compared between the two stocks.

How does Stevanato Group compare to Glaukos?

Stevanato Group (NYSE:STVN) and Glaukos (NYSE:GKOS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Stevanato Group has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Glaukos has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

Stevanato Group has a net margin of 11.76% compared to Glaukos' net margin of -34.34%. Stevanato Group's return on equity of 10.27% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Glaukos	-34.34%	-6.92%	-5.25%

Glaukos has a consensus price target of $151.77, suggesting a potential downside of 0.65%. Given Glaukos' higher possible upside, analysts plainly believe Glaukos is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83
Glaukos	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Stevanato Group has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.46	€158.21M	€0.59	33.52
Glaukos	$551.35M	16.27	-$187.69M	-$3.28	N/A

In the previous week, Glaukos had 9 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for Glaukos and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Glaukos' score of 0.65 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Glaukos	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.0% of Glaukos shares are owned by institutional investors. 5.9% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Stevanato Group beats Glaukos on 11 of the 17 factors compared between the two stocks.

Get Stevanato Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STVN vs. The Competition

Export

Metric	Stevanato Group	MED Industry	Medical Sector	NYSE Exchange
Market Cap	€5.99B	€3.05B	€7.05B	€23.46B
Dividend Yield	N/A	2.06%	2.68%	4.02%
P/E Ratio	33.52	19.17	27.11	31.08
Price / Sales	4.46	838.79	587.92	19.77
Price / Cash	22.21	56.80	29.22	18.64
Price / Book	3.56	4.22	10.75	4.77
Net Income	€158.21M	€64.26M	€3.58B	€1.06B
7 Day Performance	1.02%	-3.58%	-2.06%	-0.23%
1 Month Performance	16.09%	2.12%	3.32%	-0.11%
1 Year Performance	-22.61%	20.35%	26.35%	16.46%

Stevanato Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STVN Stevanato Group	2.7375 of 5 stars	€19.77 0.0%	N/A	-21.4%	€5.99B	€1.34B	33.52	6,010
ZBH Zimmer Biomet	3.5278 of 5 stars	$89.58 -0.2%	$102.70 +14.6%	+0.2%	$17.33B	$8.23B	23.27	17,000	Positive News
SOLV Solventum	3.9393 of 5 stars	$76.43 -1.9%	$83.73 +9.5%	+5.1%	$13.24B	$8.33B	9.37	20,000	Positive News Analyst Forecast
SNN Smith & Nephew SNATS	2.0246 of 5 stars	$30.50 -0.2%	$30.93 +1.4%	+2.6%	$12.96B	$6.16B	N/A	16,988	News Coverage
PEN Penumbra	1.6173 of 5 stars	$318.36 +0.0%	$360.33 +13.2%	+34.2%	$12.52B	$1.40B	73.36	4,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:STVN) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stevanato Group (STVN) Competitors

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

How does Stevanato Group compare to Zimmer Biomet?

Summary

How does Stevanato Group compare to Solventum?

Summary

How does Stevanato Group compare to Smith & Nephew SNATS?

Summary

How does Stevanato Group compare to Penumbra?

Summary

How does Stevanato Group compare to Glaukos?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STVN vs. The Competition

Stevanato Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stevanato Group (STVN) Competitors

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

How does Stevanato Group compare to Zimmer Biomet?

Is ZBH or STVN more profitable?

Which has preferable valuation & earnings, ZBH or STVN?

Does the media refer more to ZBH or STVN?

Which has more volatility & risk, ZBH or STVN?

Do insiders & institutionals hold more shares of ZBH or STVN?

Do analysts rate ZBH or STVN?

Summary

How does Stevanato Group compare to Solventum?

Do analysts prefer SOLV or STVN?

Which has higher earnings & valuation, SOLV or STVN?

Does the media favor SOLV or STVN?

Which has more volatility & risk, SOLV or STVN?

Is SOLV or STVN more profitable?

Summary

How does Stevanato Group compare to Smith & Nephew SNATS?

Do analysts recommend SNN or STVN?

Is SNN or STVN more profitable?

Which has more risk and volatility, SNN or STVN?

Do institutionals and insiders have more ownership in SNN or STVN?

Which has preferable valuation and earnings, SNN or STVN?

Does the media prefer SNN or STVN?

Summary

How does Stevanato Group compare to Penumbra?

Do institutionals & insiders have more ownership in PEN or STVN?

Which has stronger earnings & valuation, PEN or STVN?

Does the media prefer PEN or STVN?

Which has more volatility and risk, PEN or STVN?

Do analysts recommend PEN or STVN?

Is PEN or STVN more profitable?

Summary

How does Stevanato Group compare to Glaukos?

Which has more volatility & risk, STVN or GKOS?

Is STVN or GKOS more profitable?

Do analysts recommend STVN or GKOS?

Which has better valuation & earnings, STVN or GKOS?

Does the media prefer STVN or GKOS?

Do insiders & institutionals have more ownership in STVN or GKOS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STVN vs. The Competition

Stevanato Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools